Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Argent Biopharma ( (AU:RGT) ) is now available.
Argent Biopharma Ltd has announced its Annual General Meeting scheduled for November 28, 2025, where shareholders will address several key resolutions. These include the adoption of the Remuneration Report, election and re-election of directors, and ratification of prior share issues to Mercer Street Capital Partners and Oberon Investments Limited. The meeting will influence company governance and shareholder relations, potentially impacting its strategic direction and financial structuring.
More about Argent Biopharma
Argent Biopharma Ltd operates in the biotechnology industry, focusing on the development and commercialization of pharmaceutical products. The company is engaged in creating innovative solutions for healthcare, targeting specific market needs within the biopharmaceutical sector.
Average Trading Volume: 133,380
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$6.22M
See more data about RGT stock on TipRanks’ Stock Analysis page.